M. Dueymes et al., IGA GLYCOSYLATION ABNORMALITIES IN THE SERUM OF PATIENTS WITH PRIMARYSJOGRENS-SYNDROME, Clinical and experimental rheumatology, 13(2), 1995, pp. 247-250
Since there is no information regarding the glycosylation status of im
munoglobulin A (IgA) in patients with primary Sjogren's syndrome (pSS)
, the sialic acid and galactose contents of IgA1 and IgA2 were evaluat
ed in 17 pSS patients and in 14 normal controls (NC), using new enzyme
-linked immunosorbent assays. The proportion of sialylated IgA1 and Ig
A2 was augmented (p < 0.001 and < 0.05, compared with NC), whereas tha
t of galactosylated IgA1 and IgA2 was reduced (p < 0.01 and < 0.02, re
spectively). The level of SA IgA1 correlated with the amount of IgA-co
ntaining immune complexes (p < 0.01), serum IgA (p < 0.02) and IgA-rhe
umatoid factor (p < 0.01). This demonstrates a number of IgA abnormali
ties in PSS patients. There were no correlations between SA and Gal, h
owever nor could any difference be ascribed to extraglandular manifest
ations.